B. Crosse

发表

Randomized Prospective Biomarker Trial of ERCC1 for Comparing Platinum and Nonplatinum Therapy in Advanced Non-Small-Cell Lung Cancer: ERCC1 Trial (ET).

A. Hackshaw, M. Nicolson, J. Spicer, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer.

G. Hillerdal, M. Nicolson, Y. Summers, 2015, Lung cancer.

Aggressive management of non-small cell lung cancer with synchronous solitary brain metastasis.

N. Vasudev, B. Crosse, J. Joffe, 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

S85 British Thoracic Oncology Group Trial, BTOG2: Randomised phase III clinical trial of gemcitabine combined with cisplatin 50 mg/m2 (GC50) vs cisplatin 80 mg/m2 (GC80) vs carboplatin AUC 6 (GCb6) in advanced NSCLC

D. Dunlop, K. O'Byrne, L. Billingham, 2011, Thorax.

Psittacosis: a clinical review.

B. Crosse, 1990, The Journal of infection.

Ovine psittacosis and sarcoidosis in a pregnant woman.

B. Crosse, M. Muers, P. Gomes, 1991, Thorax.

Severe Herpes Zoster Infection in the United Kingdom: Experience in a Regional Infectious Disease Unit

B. Crosse, P. Bannister, 1989, Journal of the Royal Society of Medicine.

Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)

A. Hackshaw, M. Seckl, P. Schmid, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hepatitis B markers in West Yorkshire firemen

B. Crosse, C. Teale, E. M. Lees, 1989, Epidemiology and Infection.

Splenic abscess associated with Salmonella infection: successful medical treatment.

B. Crosse, 1989, The Journal of infection.

HIV infection and foreign travel.

B. Crosse, D. Maher, 1990, BMJ.

Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer

D. Dunlop, K. O'Byrne, L. Billingham, 2017 .

cell lung cancer : Results from a British Thoracic Oncology Group randomised phase III trial

K. O'Byrne, L. Billingham, M. Nicolson, 2017 .

S87 Delivered dose intensity of gemcitabine 1250 mg/m2 with cisplatin at 80 mg/m2 (GC80) and 50 mg/m2 (GC50) and carboplatin AUC 6 (GCb6) in a phase III trial of advanced non-small cell lung cancer (NSCLC): correlations with clinical outcomes

D. Dunlop, K. O'Byrne, L. Billingham, 2011, Thorax.

S86 Quality of life in advanced non-small cell lung cancer, effects of cisplatin dose and carboplatin in combination with gemcitabine: results from BTOG2, a British Thoracic Oncology Group phase III trial in 1363 patients

D. Dunlop, K. O'Byrne, M. Nicolson, 2011, Thorax.

Gastroduodenal obstruction from ovarian cancer: imaging features and clinical outcome.

J. Spencer, T. Perren, B. Crosse, 2000, Clinical radiology.

Computed Tomography Findings of Gaseous Necrosis in Epithelial Ovarian Cancer: A Report of Three Cases

J. Spencer, P. Cronin, B. Crosse, 2002, Journal of computer assisted tomography.

Subcutaneous and mediastinal emphysema complication of measles.

B. Crosse, 1989, The Journal of infection.

Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial

D. Dunlop, K. O'Byrne, L. Billingham, 2017, European journal of cancer.